MRC LMS Highlights Josca Schoonejans’ Research on Gestational Diabetes Treatments
MRC Laboratory of Medical Sciences (LMS) shared on LinkedIn:
“This World Diabetes Day, we’re shining a spotlight on Josca Schoonejans and her research into improving treatments for gestational diabetes.
Around 1 in 7 women worldwide develops gestational diabetes, a type of diabetes first diagnosed during pregnancy.
Metformin is a commonly used treatment and poses no immediate risk to parent or baby. However, questions remain about its potential long-term effects on babies exposed during pregnancy.
Josca’s research is exploring whether ursodeoxycholic acid (UDCA), a medication already used to treat liver conditions during pregnancy, could offer a safer alternative.
At the LMS, we’re working to understand the biology behind disease and use those insights to improve people’s health. Studies like this could help shape safer treatments for women with gestational diabetes and their babies in the future.
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 16, 2026, 19:39Ting Yuan: Rethinking Endometrial Preparation in FET
-
Nov 16, 2026, 19:35Rima Dhillon-Smith: Feeling Inspired After the ESHRE Campus on Comprehensive Approaches to Pregnancy Loss
-
Nov 16, 2026, 19:32Nominations for ARCS Awards 2027 Close 30th November
-
Nov 16, 2026, 19:30Suganya Venkat: Let Me Say This Clearly – PMS Is Real
-
Nov 16, 2026, 19:28Elena Milner: Exploring Emerging Technologies in the IVF Laboratory
-
Nov 16, 2026, 19:24Serena H. Chen: How Individuals Working Together Can Truly Make a Difference
-
Nov 16, 2026, 19:22Rajeev Agarwal: An Open Tube Is Not Always A Working Tube
-
Nov 16, 2026, 19:20Karthik Raj: DuoStim in IVF
-
Nov 16, 2026, 19:16Rana Mondal: Navigating Reproductive Decision-Making Alongside Elevated Hereditary Cancer
